Statement of Organization, Functions, and Delegations of Authority, 22821-22829 [2010-9910]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Pages 22821-22829]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9910]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority the 
Department of Health and Human Services (45 FR 67772-76, dated October 
14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended 
most recently at 75 FR 14608, dated March 26, 2010) is amended to 
reflect the reorganization of the Center for Global Health, Centers for 
Disease Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows: Delete in their entirety the titles and functional statements 
for the Center for Global Health (CW), and insert the following:
    Center for Global Health (CW). The Center for Global Health (CGH): 
(1) Leads the execution of the Center for Disease Control and 
Prevention's (CDC) global health strategy; (2) works in partnership to 
assist Ministries of Health to plan, manage effectively, and evaluate 
health programs; (3) achieves U.S. Government program and international 
organization goals to improve health, including disease eradication and 
elimination targets; (4) expands CDC's global health programs that 
focus on the leading causes of mortality, morbidity and disability, 
especially chronic disease and injuries; (5) generates and applies new 
knowledge to achieve health goals; and (6) strengthens health systems 
and their impact.
    Office of the Director (CWA). (1) Provides strategic direction and 
guidance on the execution of CDC's global health strategy including 
decision-making, policy development and program planning and 
evaluation; (2) ensures the impact and effectiveness of 
Congressionally-mandated programs; (3) improves implementation and 
coordination of CDC global programs; (4) harmonizes CDC global health 
priorities with host country priorities to improve essential public 
health functions and maximize positive health outcomes, country 
ownership and sustainability; (5) supervises all CDC country directors 
and provides leadership in the selection of additional countries to 
expand or establish collaboration; (6) measures the performance of 
CDC's global health programs in terms of public health impact and 
fiscal accountability; (7) facilitates the conduct and maintenance of 
ethical and high quality, evidence-based scientific investigations by 
implementing regulatory requirements, monitoring human subjects 
compliance, and clearing scientific products; (8) promotes cross-
cutting agendas and harmonizes CDC's global laboratory science 
activities to improve diagnostic methodologies and respond to threats 
of emerging pathogens; (9) provides leadership to promote growth of CDC 
global health programs; (10) analyzes, measures, and evaluates the 
global burden and distribution of disease; (11) promotes scientific 
innovation and best technical practices in global health surveillance, 
epidemiology, outbreak investigation, monitoring and evaluation, and 
informatics; (12) provides leadership on issues management, budget 
formulation and performance integration, and country-specific issues 
through triaging to programs; (13) participates in defining, 
developing, shaping and implementing U.S. global health policy and 
actions; (14) manages inter-governmental and

[[Page 22822]]

external affairs and cultivates strategic partnerships; (15) plans and 
executes CDC's global health communications strategy and public affairs 
media response/outreach; (16) provides oversight, guidance, and 
accountability for all operations functions, human resources, workforce 
management, budget formulation and distribution, extramural reviews and 
processing, internal and domestic travel, and property management 
responsibilities of CGH; and (17) develops standardized management 
processes and solutions for CDC country offices.
    Division of Public Health Systems and Workforce Development (CWF). 
The Division of Public Health Systems and Workforce Development 
(DPHSWD) contributes to improving the health of the people of the U.S. 
and other nations by partnering with relevant foreign government 
ministries, educational institutions, Federal agencies, and 
international organizations to strengthen capacity of countries around 
the world to improve public health. To carry out its mission, the 
division performs the following functions: (1) Works with partners to 
build strong, transparent, and sustained public health systems through 
training, consultation, capacity building, and technical assistance in 
applied epidemiology, public health surveillance, evaluation, 
operational and implementation research, and laboratory systems; and 
promotes organizational excellence in public health through 
strengthening leadership and management capacity; (2) assists in 
developing and implementing CGH policy on public health system 
strengthening and sustainability; (3) collaborates with other CDC 
organizations, Federal agencies, international agencies, partner 
countries, and non-governmental organizations assisting ministries of 
health to build public health capacity in other areas of public health; 
and (4) supports and performs primary research on health systems and 
health systems performance that are relevant to the improvement of the 
division's own programs as well as the programs with which it 
collaborates.
    Office of the Director (CWF1). (1) Provides leadership, overall 
direction, and evaluation for the division; (2) formulates and 
coordinates execution of CDC's strategy for developing global public 
health capacity in applied epidemiology, public health systems 
management and leadership; (3) provides leadership and guidance on 
policy, program planning, program management, and operations; (4) 
plans, allocates, and monitors resources; (5) formulates, executes, and 
monitors CORE budgets; (6) monitors and assists in the formulation and 
execution of branch and county project's budgets; (7) provides support 
and assistance to the branches in management, administrative, and 
personnel services; (8) develops and manages cooperative agreements, 
grants and contracts; (9) develops and disseminates communication 
material; (10) provides leadership in assisting national ministries of 
health, international agencies, and nongovernmental organizations in 
the delivery of epidemiologic services and the development of 
international epidemiologic networks; (11) liaises with other CDC 
organizations, other Federal agencies, ministries of health, and 
international organizations; (12) provides consultations with partners 
and stakeholders including nongovernmental organizations and the 
private sector on program development and overall public health systems 
and sub-systems; (13) develops and produces communication materials 
documenting the division's public health programs, accomplishments, and 
impact (e.g., annual reports, newsletters, Web sites, training 
materials); (14) develops and maintains intranet and internet Web sites 
for the division and its programs; (15) provides consultation and 
technical assistance to programs and partners in scientific 
communication, health communication, and public health marketing 
programs; and (16) assesses scientific communication needs for 
partners, and develops and delivers public health materials and 
information, and training tailored to the specific needs of the 
partners.
    Sustainable Management Development Program (CWF12). (1) Partners 
with ministries of health, educational institutions, and 
nongovernmental organizations to promote organizational excellence in 
public health through strengthening leadership and management capacity; 
(2) works with partners to build capacity for public health leadership 
and management development through a multi-phased approach including 
situational analysis, capacity development, technical assistance, and 
sustainability; (3) develops strategic institutional partnerships for 
public health leadership and management capacity-building efforts; (4) 
develops faculty to enhance in-country leadership and management 
training capacity through the Management for International Public 
Health course and in-country training-of-trainers; (5) provides support 
to training faculty in partner institutions to conduct performance 
needs assessments; develops locally appropriate curricula; and designs 
in-country leadership and management workshops that provide 
participants with practical skills needed to manage public health 
teams, programs, and organizations; (6) works with partner institutions 
to ensure the long-term sustainability of global public health 
leadership and management development programs; and (7) supports and 
performs primary operational and implementation research in support of 
continuous improvement of its own and partners' leadership and 
management programs.
    FELTP and Systems Development Branch (Africa) (CWFB). (1) With 
partners, designs and conducts evidence-based instruction in public 
health disciplines needed to strengthen their public health systems, 
including instructional design, epidemiology, surveillance, laboratory 
operations and management, communications, and economic evaluation; (2) 
assists ministries of health in the African region and elsewhere to 
develop sustainable field epidemiology and laboratory training programs 
for public health systems strengthening; (3) develops models for 
continuous tracking and improvement of critical outputs and outcomes 
from field epidemiology and laboratory training programs around the 
world; (4) working with DPHSWD technical program components, provides 
consultation to ministries of health in development of surveillance 
systems (e.g., communicable and non communicable disease surveillance, 
injury, chronic diseases, etc.); (5) coordinates CDC's support the 
World Health Organization's (WHO) Integrated Disease Surveillance and 
Response strategy; (6) creates and maintains division wide computer-
based and distance-based learning methods, and develops the capacity of 
partners to create, evaluate, and share their own; (7) develops and 
evaluates competency based training materials for the FETP and similar 
program for use of the division and its partners; (8) maintains a 
divisional training material library and website; and (9) collaborates 
within CDC and with national or international organizations in 
development of competency-based training materials, evaluation of 
training, and design of surveillance systems needed to accomplish the 
mission.
    FELTP and Systems Development Branch (Asia and the Americas) 
(CWFC). (1) Assists partners in assessing their needs for health 
systems strengthening; (2) plans, directs,

[[Page 22823]]

supports, implements, and coordinates field epidemiology and laboratory 
training programs, Data for Decision Making Projects, operational and 
implementation research projects, and other partnerships with 
ministries of health; (3) provides leadership and management oversight 
in assisting ministries of health in capacity building by training 
epidemiologists and other health professionals through the development 
of competency based, residency-style, applied training programs; (4) 
provides leadership and expertise in assisting national ministries of 
health to utilize trained public health workers for developing health 
policy, and implementing and evaluating health programs; (5) assigns 
and manages expert consultants as long-term, in-country advisors to 
ministry of health programs; (6) collaborates within CDC, with other 
Federal agencies, and with national and international organizations in 
support of partner programs; (7) provides consultation to ministries of 
health in development of surveillance systems (e.g., communicable and 
non-communicable disease surveillance, injury, chronic diseases, etc.); 
(8) develops and evaluates competency-based training materials for the 
FETP and similar programs for use of the division and its partners; and 
(9) collaborates within CDC and with national or international 
organizations in development of competency-based training materials, 
evaluation of training, and design of surveillance systems needed to 
accomplish mission.
    Division of Global HIV/AIDS (CWG) The Division of Global HIV/AIDS 
(DGHA) provides technical assistance to host governments, working 
through its strong partnerships with Ministries of Health and local and 
international partners to implement integrated HIV/AIDS clinical and 
preventive services and systems; develop and strengthen laboratory 
services; and provide epidemiologic science, informatics, and research 
support to develop sustainable public health systems in resource-
constrained countries. DGHA: (1) Provides leadership, management, and 
services to DGHA country offices; (2) implements integrated evidence-
based prevention, care, and treatment programs and services; (3) 
evaluates program cost effectiveness and impact to assist with 
prioritization, inform program planning, and determine appropriate 
rates of program expansion, and supports transition of responsibility 
for implementation of HIV programs to indigenous partners and 
Ministries of Health; (4) builds sustainable public health capacity in 
laboratory services and systems; (5) ensures epidemiologic and 
scientific excellence in HIV/AIDS programs; (6) contributes to the 
broader scientific body of knowledge in global public health by 
systematically evaluating the scope and quality of global HIV/AIDS 
programs; (7) implements operations and effectiveness research to 
inform the design of current and future programs as well as optimize 
allocation of human and financial resources; (8) strengthens in-country 
capacity to design and implement HIV/AIDS surveillance systems and 
surveys; (9) builds host government public health management capacity 
and trains in-country public heath workforce with the goal of long term 
program sustainability; (10) supports host government capacity to 
monitor and evaluate the process, outcome, and impact of HIV 
prevention, care, and treatment programs, and (11) helps countries 
respond to public health emergencies, assisting in response planning 
and implementation with Ministries of Health and other international 
partners.
    Office of the Director (CWG1). (1) Provides strategic leadership, 
guidance, management and oversight to all DGHA programs and ensures 
coordination and communication across its branches and with other CDC 
programs including CDC/Washington; U.S. Government (USG) agencies, 
including the Department of Health and Human Services (HHS), the United 
States Agency for International Development (USAID), and Department of 
State (DoS); and other international organizations; (2) plans, 
implements, and oversees all field programs along with other USG 
agencies; (3) manages all DGHA country directors and provides 
leadership and guidance to country offices in all matters of daily 
operation, including management of global workforce staff; (4) provides 
leadership and guidance on policy development and interpretation, 
budget formulation, program planning, issues management, management and 
operations, and evaluation; (5) helps to build capacity and strengthen 
the public health response by sharing best practices through 
communication materials and coordinating dissemination of resources to 
the media, partners, and other audiences; (6) identifies opportunities 
for leveraging and enhancing partnerships for public health protection 
and synergies with other Agency programs and partners; (7) provides 
DGHA management and operations services in coordination with 
appropriate CDC staff offices, including processing travel and 
assisting with accountability and management of HHS/CDC property, 
facilities, and equipment; (8) ensures timely and sufficient DGHA 
domestic staff placement through recruitment, hiring, and orienting of 
qualified staff; (9) ensures retention of qualified staff by providing 
workforce management and career development services for DGHA domestic 
staff; (10) ensures scientific excellence for all DGHA scientific, 
programmatic, and informational documents/materials which includes 
providing scientific review and clearance of manuscripts for 
publication, abstracts for presentation, and protocols for 
institutional review boards and human subjects review; (11) provides 
coordination and support for, as well as contributes to, global public 
health evaluation and operational research to maximize the 
effectiveness and quality of global HIV/AIDS interventions to guide 
DGHA programs and policies; (12) establishes and implements standards 
for organizational excellence; (13) provides direct technical 
assistance and maintains relationships with host country partners and 
responds to other health needs as required; (14) assures accountability 
of program funds and reports on progress; and (15) collaborates with 
other CDC and HHS programs and offices; other USG agencies; and other 
national and international organizations.
    International Laboratory Branch (CWGB). (1) Serves as a reference 
laboratory that provides guidance on quality assurance and 
certification for international sites; (2) provides technical 
assistance to country programs in the areas of laboratory information 
systems and laboratory systems; (3) provides training packages, 
training, guidance, and support to host nations, other USG agencies and 
international and national partners on HIV, Sexually Transmitted 
Infection (STI), and opportunistic infection (OI) diagnostics and 
monitoring techniques; HIV incidence testing; hematology; chemistry; 
CD4; TB/OI testing; antiretroviral treatment (ART) resistance testing; 
dried blood spot polymerase chain reaction for early infant diagnosis; 
viral load monitoring; and ensuring the quality of laboratories and 
testing activities; (4) serves as a training center of excellence for 
HIV/STI/OI diagnostics for international sites; (5) provides laboratory 
assistance to international surveillance activities to monitor trends 
of HIV prevalence and incidence; (6) assists in the surveillance of HIV 
subtypes in the overall context of supporting sero-surveillance 
programs; (7) assists in the surveillance and evaluation of HIV drug 
resistance as part of antiretroviral care and treatment

[[Page 22824]]

programs and serves as a reference laboratory for the World Health 
Organization (WHO)-CDC HIV drug resistance network; (8) develops 
strategies and methodologies to meet the clinical and diagnostic needs 
of HIV/AIDS programs; (9) assists in the evaluation and validation of 
serologic and nucleic acid assays for measurement of HIV incidence to 
enable evaluation of effectiveness of prevention programs; (10) 
develops comprehensive testing algorithms for HIV diagnosis; (11) 
contributes to operational research to maximize the effectiveness and 
quality of global HIV/AIDS interventions to guide DGHA programs and 
policies; (12) conducts laboratory capacity assessments and assists in 
development of infrastructure for effective implementation of programs 
in countries where DGHA operates; (13) provides laboratory guidance and 
support on national strategic planning and quality management of tiered 
laboratory systems in host nations and consults on all technical 
aspects of laboratory procurement, standardization, quality control and 
quality assurance; (14) works with international accrediting 
organizations to establish guidance, training, and tools for 
accreditation of laboratory systems in resource-poor settings; (15) 
supports ongoing collaboration with international laboratory experts 
and national and regional laboratory personnel to resolve technical 
issues and develops international tools, guidelines, curriculum and 
other resources to improve laboratory capacity in host nations; (16) 
develops and implements strategies to expand the laboratory health 
workforce and increase human capacity of host government public health 
programs to strengthen and ensure a sustainable public health response 
to HIV/AIDS; (17) promotes a transition toward greater sustainability 
of laboratory systems through the support of country-driven efforts; 
(18) establishes strategic Public Private Partnerships for 
strengthening laboratory systems, training, development of referral 
systems for transporting samples, and quality management schemes; (19) 
ensures scientific excellence for all branch manuscripts, protocols, 
and programs in collaboration with the DGHA Office of the Director (OD) 
Science Office; (20) contributes to the greater body of scientific 
knowledge through the presentation of laboratory operational research 
findings at conferences and through publications in peer reviewed 
journals; and (21) collaborates with other DGHA branches; other CDC and 
HHS programs and offices; other USG agencies; and other national and 
international organizations.
    HIV Prevention Branch (CWGC). (1) Provides technical assistance and 
builds capacity to implement, improve, expand, sustain, and maximize 
effectiveness of HIV prevention programs; (2) provides technical 
assistance for scale-up of prevention and biomedical interventions and 
linkage with other HIV clinical services; (3) assists DGHA country 
programs in the recruitment of safe blood (products) donors, quality 
testing, blood bank management, appropriate use of blood and blood 
products, and prevention of severe anemia; (4) fosters the improvement 
of HIV prevention and counseling services through blood donor 
education, mobilization, and retention of safe blood donors; (5) 
supports development of safe injection practices, improved sharps waste 
management, safer blood transfusions, and avoidance of unnecessary 
medical injections; (6) assists in the development, implementation, and 
evaluation of model behavior change interventions and programs to 
reduce risk-behaviors and enhance health-seeking behaviors; (7) helps 
strengthen, expand, and make accessible programs to prevent, diagnose, 
and treat STIs in high risk populations and to prevent HIV infection 
among persons seeking treatment for STIs; (8) assists in tailoring HIV 
prevention programs to meet the special needs of youth and drug-using 
populations; (9) helps to develop, expand, and evaluate voluntary HIV 
counseling and testing programs in both clinical and community 
settings; (10) assists in the provision of technical support to DGHA 
programs in developing laboratory, clinical, and administrative 
capacities to prevent HIV/AIDS; (11) assists in implementing, and 
monitoring the quality and impact of, prevention programs for persons 
living with HIV/AIDS and their families and integrating HIV prevention 
programs within health services for HIV care and treatment; (12) 
assists in safe and effective implementation of biomedical 
interventions, including the scale-up of male circumcision; (13) 
assists in monitoring the training of health care workers to prevent 
HIV; (14) contributes to operational research to maximize the 
effectiveness and quality of global HIV/AIDS interventions to guide 
DGHA programs and policies; (15) establishes strategic Public Private 
Partnerships to build capacity for and maximize effectiveness of HIV 
prevention programs in host countries; (16) ensures scientific 
excellence for all branch manuscripts, protocols, and programs in 
collaboration with the DGHA OD Science Office; and (17) collaborates 
with other DGHA branches; other CDC and HHS programs and offices; other 
USG agencies; and other national and international organizations.
    HIV Care and Treatment Branch (CWGD). (1) Provides technical 
assistance and builds capacity in developing and implementing 
sustainable comprehensive care and treatment programs for persons with 
HIV/AIDS. This includes prevention, diagnosis, and treatment services 
for HIV/AIDS, tuberculosis, other opportunistic infections, and 
opportunistic cancers; (2) provides technical expertise and support to 
country programs, partners, and Ministries of Health in planning, 
implementing, and evaluating effective strategies for care and 
treatment of persons with HIV; (3) provides HIV care and treatment 
expertise to country programs, partners, and Ministries of Health on 
management, standard operating procedures, human resources, physical 
infrastructure, training, drug and health commodities management, 
laboratory services, monitoring and evaluation, community services, 
linkage between HIV and other programs, promotion of prevention, and 
sustainability; (4) provides support for continuous quality improvement 
of HIV care and treatment programs; (5) promotes appropriate 
integration of services, including HIV prevention interventions into 
clinical care and treatment settings and HIV services into general 
medical services; (6) conducts operational research in collaboration 
with country programs to identify best practices, address barriers, and 
respond to emerging scientific issues related to HIV care and treatment 
service delivery; (7) collaborates with international partners to 
synthesize the scientific body of knowledge on HIV care and treatment, 
including TB/HIV co-infection; (8) collaborates with international 
partners to develop and disseminate tools (e.g., protocols and training 
curricula), guidelines and policies; (9) supports analysis of program 
costs and cost effectiveness to assist with prioritization, inform 
program planning, and determine appropriate rates of program expansion; 
(10) supports capacity building of host countries to transition 
responsibility for implementation of HIV care and treatment services to 
indigenous partners and Ministries of Health, with result of increasing 
ownership, sustainability and service delivery cost

[[Page 22825]]

efficiencies; (11) establishes strategic Public Private Partnerships 
aimed at augmenting capacity for developing and implementing 
sustainable comprehensive care and treatment programs, including 
prevention, diagnosis, and treatment services for HIV/AIDS, 
tuberculosis, other opportunistic infections, and opportunistic 
cancers; (12) ensures scientific excellence for all branch manuscripts, 
protocols, and programs in collaboration with the DGHA OD Science 
Office; (13) collaborates with other DGHA branches; other CDC and HHS 
programs and offices; other USG agencies; and other national and 
international organizations.
    Maternal and Child Health Branch (CWGE). (1) Supports the 
international scale up of comprehensive, quality prevention of mother-
to-child HIV transmission (PMTCT) and pediatric (Peds) programs by 
developing adaptable training tools, utilizing operational research to 
identify and implement models of service delivery adapted to district, 
regional, sub-national and national contexts; (2) provides technical 
expertise and support to countries in planning, implementing, and 
evaluating effective strategies for scaling up of sustainable programs 
for the prevention, diagnosis, and treatment of HIV/AIDS, tuberculosis, 
and other opportunistic infections in women, infants, and children, 
including linking PMTCT/Peds HIV programs with HIV clinical and 
preventive services and other maternal and child health settings/
contexts; (3) builds national capacity for and provides guidance on 
development of policy for formulations for and access to appropriate 
long-term combination ART for HIV-infected children; (4) conducts 
operational research in collaboration with country programs to promote 
best practices, address barriers, and respond to emerging scientific 
issues for PMTCT/Peds HIV service delivery; (5) collaborates with 
international partners to contribute to the scientific body of 
knowledge on global PMTCT/Peds and broader maternal arid child health 
issues and to develop and disseminate tools, guidelines, and policies 
to translate research for improved program implementation in resource-
constrained countries; (6) provides support for continuous quality 
improvement of PMTCT and Peds HIV care and treatment programs, 
including those within broader maternal and child health programs; (7) 
supports analysis of program costs and cost-effectiveness to assist 
with prioritization, inform program planning, and determine appropriate 
rates of program expansion; (8) acts as a key part of a broader CDC 
strategic response to address health needs and gender-related issues of 
maternal and child health worldwide, supporting a comprehensive, 
multidisciplinary approach to building maternal and child health 
services and systems capacity in host countries; (9) establishes 
strategic Public Private Partnerships for HIV maternal and child health 
services and systems capacity in host countries; (10) ensures 
scientific excellence for all branch manuscripts, protocols, and 
programs in collaboration with the DGHA OD Science Office; and (11) 
collaborates with other DGHA branches; other CDC and HHS programs and 
offices; other USG agencies; and other national and international 
organizations.
    Epidemiology and Strategic Information Branch (CWGG). (1) Assists 
countries in developing and/or enhancing HIV-related surveillance 
systems and in using the results of surveillance surveys for impact 
monitoring, program planning, and HIV/AIDS policy making; (2) assists 
and provides training on analyzing, disseminating, and using HIV/AIDS 
data; (3) assists and provides training to CDC programs and host 
country governments to assess and ensure the quality of the data 
collected in HIV-related surveillance systems and HIV/AIDS program 
monitoring systems; (4) strengthens host government capacity to monitor 
and evaluate the process, outcome, and impact of HIV/AIDS prevention, 
care, and treatment programs, other related global health programs, and 
health systems through the development of guidelines, curricula, and 
other tools; (5) implements and evaluates novel approaches for 
conducting surveillance and surveys, and conducting program monitoring 
and evaluation; (6) performs epidemiologic investigations of HIV/AIDS 
as well as provides statistical and epidemiologic technical assistance 
for in-country investigations; (7) supports surveys and monitoring and 
evaluation systems that measure HIV prevalence, changes in HIV-related 
behavior, and health status among individuals and at the population 
level; (8) strengthens country monitoring systems that track program 
service delivery and ensure effective, evidence based programming; (9) 
provides support to the DoS Office of the US Global AIDS Coordinator 
(OGAC) and to interagency USG in-country teams to monitor and evaluate 
the outputs, outcomes, and impact of global HIV/AIDS activities and 
advises interagency in-country teams on planning of strategic 
information activities; (10) improves the collection and analysis of 
data through development of guidelines on HIV surveillance and assists 
countries to develop procedures to standardize HIV surveillance 
systems, write protocols for HIV surveillance, train for data 
collection, and assist with data cleaning and data analysis; (11) 
provides a wide range of statistical and epidemiologic support and 
technical expertise to agencies and staff engaged in global HIV/AIDS 
activities, including consultation and direct assistance at all stages 
of a public health study; specifically, development of study design, 
sample size and power estimation, questionnaire design, data 
monitoring, statistical analysis and report writing; (12) provides 
comprehensive data management support to staff and countries engaged in 
global HIV/AIDS activities, including development of data organization 
plan and standards for coding of data elements, quality assurance, 
maintenance of databases, report generation, and implementation of 
policies on electronic record retention and data security; (13) 
coordinates, oversees, or assists in the formulation of epidemiology 
and strategic information funding/budgets and in the execution of a 
variety of acquisition and assistance awards; (14) ensures scientific 
excellence for all branch manuscripts, protocols, and programs in 
collaboration with the DGHA OD Science Office; and (15) collaborates 
with other DGHA branches; other CDC and HHS programs and offices; other 
USG agencies; and other national and international organizations.
    Health Economics, Systems, and Integration Branch (CWGH). (1) 
Identifies priority information needs for program planning, resource 
allocation, efficiency and program integration, and develops economic 
analysis and operational research activities; (2) implements economic 
studies, including costing and cost-effectiveness studies, and applies 
advanced modeling techniques to inform and optimize global health 
planning, policy and programs, and provide a broader understanding of 
the effects of health programs on improving economic and other non-
health outcomes; (3) supports USG efforts in projecting financing needs 
to efficiently meet program targets in areas of prevention, care and 
treatment, and human resources for health (HRH); (4) guides development 
and implementation of monitoring systems to routinely capture program

[[Page 22826]]

expenditure data to support planning, accountability and efficient 
programming; (5) trains and mentors partner country personnel in the 
methods and application of economic analysis of global health programs 
and policy; (6) provides technical input, guidance, review and 
implementation support to operational research on and evaluation of 
global HIV/AIDS activities; (7) supports the development of partner 
country health finance systems and capacity to develop sustainable and 
accountable programs, and assists in the implementation of national 
AIDS spending assessment activities; (8) assists countries in the 
collection, transmission, classification, storage, and analysis of 
strategic information, and helps countries to design, implement, 
maintain, and evaluate a wide range of information systems to both 
support implementation of global HIV/AIDS services, and to monitor and 
evaluate the results to inform policy and program decisions; (9) 
supports the integration of HIV data into broader, more comprehensive 
health information systems, supports development of comprehensive 
health information systems, and works to ensure that systems are not 
duplicative; (10) works with in-country counterparts to provide 
technical assistance on strengthening health information systems in-
country, including systems needs assessments, identifying and resolving 
DGHAs, describing data exchanges needed across these systems, and 
developing standards for data and for system interoperability; (11) in 
conjunction with WHO/Joint United Nations Program on HIV/AIDS develops: 
standardized definitions for data that support ART, HIV/TB, maternal 
child health, PMTCT, and other clinical care; open source tools for the 
implementation of electronic patient record and other systems; security 
and confidentiality guidance for HIV/AIDS data; guidance on unique 
identification and matching of patient records across disparate 
information systems; (12) participates in USG interagency technical 
working groups and provides technical leadership to address global 
health information systems, Health Systems Strengthening (HSS), and HRH 
issues and initiatives; (13) provides technical support for the routine 
monitoring of health related governance including financial 
accountability, programmatic transparency, policy development and 
enforcement, and engagement and regulation of the private health 
sector, including the Global Fund to Fight AIDS, Tuberculosis, and 
Malaria; (14) develops the HSS operational research agenda for DGHA and 
implements public health evaluations related to health systems; (15) 
provides broad HSS technical assistance and support to USG in-country 
teams and host countries to improve the delivery of HIV and other 
health services and work toward transition to country ownership of 
program; (16) supports branches in strengthening health systems, 
developing metrics to assess DGHA's contribution to HSS and 
implementing monitoring systems to routinely collect DGHA's health 
system impact, especially in the areas of laboratory systems, maternal 
child health services, HIV care and treatment service delivery, blood 
safety programs, and prevention services; (17) helps define CDC's role 
and identify priority needs for strengthening HRH to support 
sustainability of HIV programs; (18) provides HRH technical assistance 
and other support to meet priority HRH needs, including pre-service and 
in-service training, task-shifting, capacity-building of accreditation 
and credentialing bodies, HRH planning and management, workplace 
performance and safety, and the development of human resource 
information systems and their use in health decision-making; (19) 
conducts monitoring and evaluation of US-supported HRH activities, to 
help inform U.S. resource and program decision-making; (20) ensures 
that public health epidemiologists, laboratorians, and administrators 
are represented in the goal of training and retaining 140,000 new 
health professionals; (21) supports operational research activities and 
public health evaluations that address current HRH questions and 
monitoring needs; (22) ensures scientific excellence for all branch 
manuscripts, protocols, and programs in collaboration with the DGHA OD 
Science Office; and (23) collaborates with other DGHA branches; other 
CDC and HHS programs and offices; other USG agencies; and other 
national and international organizations.
    Country Operations Branch (CWGJ). (1) Provides operations support 
to facilitate effective delivery of global HIV/AIDS activities in DGHA 
country programs in the areas of fiscal management, procurement, 
personnel, extramural (grants, cooperative agreements and contracts) 
programs, and other administrative services; (2) serves as the key 
linkage between DGHA headquarters and DGHA country offices coordinating 
calls and liaising with the CDC Financial Management Office (FMO) and 
Procurement and Grants Office (PGO), Atlanta Human Resources Center, 
and OGAC; (3) serves as the CDC representative on the OGAC core team/
country support team; (4) develops strategies to improve the technical 
skills and problem-solving abilities of country program managers and 
locally employed staff who work in the administrative, management and 
operational area; (5) provides short- and long-term consultation, 
technical assistance, and backstopping for management and operations 
issues and staff to DGHA country offices; (6) provides long-term 
management and operations support for smaller countries; (7) ensures 
timely and sufficient CDC international staff placement through 
recruitment, hiring, orienting, deploying, and assisting with 
relocation of qualified staff; (8) ensures retention of qualified staff 
by providing workforce management and career development services for 
CDC international staff; and (9) collaborates with other DGHA branches; 
other CDC and HHS programs and offices; other USG agencies; and other 
national and international organizations.
    Program Budget and Extramural Management Branch (CWGK). (1) 
Coordinates all DGHA procurement and extramural activities in creating 
spend plans in compliance with federal appropriations law, 
congressional intent, and global HIV/AIDS policies; (2) facilitates and 
manages the development, clearance, and award of all new and ongoing 
DGHA headquarters and field grants, cooperative agreements, and 
contracts; (3) provides technical assistance and guidance to the 
countries and branches on budget and extramural issues including 
assisting programs in determining the appropriate funding mechanism to 
support global HIV/AIDS activities; (4) provides training and tools to 
DGHA country programs to improve budget and cooperative agreement 
management; (5) manages DGHA headquarters budget and tracks overall 
DGHA budget, which includes conducting budget planning exercises and 
managing the annual close-out process; (6) provides funding and 
budgetary data for regular reports including the Headquarters 
Operational Plan, GAO and IG audits, country Annual Program Results to 
OGAC, and other requests for data; (8) reviews and provides input on 
budgetary and procurement policy-related documents; (9) liaises and 
collaborates, as appropriate, with the DGHA Associate Director for 
Science, other financial and procurement-related units and offices 
including FMO and PGO, as well as other CDC and HHS offices, OGAC, and

[[Page 22827]]

other USG agencies; (10) collaborates with other DGHA branches; other 
CDC and HHS programs and offices; other USG agencies; and other 
national and international organizations. Division of Parasitic 
Diseases and Malaria (CWH). The Division of Parasitic Diseases and 
Malaria (DPDM) prevents and controls parasitic diseases in the U.S. and 
throughout the world by providing diagnostic, consultative, 
epidemiologic services, and training. In carrying out its mission, 
DPDM: (1) Conducts surveillance, investigations, and studies of 
parasitic diseases to define disease etiology, mode of transmission, 
and populations at risk, and to develop effective methods for 
diagnosis, prevention, control, and elimination; (2) conducts or 
participates in clinical, field, and laboratory research to develop, 
evaluate, and improve laboratory methodologies, materials and 
therapeutic practices used for rapid and accurate diagnosis and 
treatment of parasitic diseases; (3) provides epidemic aid, 
epidemiologic consultation, and reference diagnostic services to state 
and local health departments, other federal agencies, and national and 
international health organizations; (4) conducts a program of 
laboratory and field research in the biology, ecology, and host-
parasitic relationships to develop better methods for diagnosis, 
prevention, and control of parasitic diseases; (5) provides scientific 
and technical assistance to other components within CDC when the work 
requires unique expertise or specialized equipment not available in 
other CDC components; (6) serves as WHO Collaborating Centers for 
Cysticercosis, Research Training and Eradication of Dracunculiasis, 
Control and Elimination of Lymphatic Filariasis, Evaluating and Testing 
New Insecticides, Insecticide Resistance, Insect Vectors; Malaria 
Control in Africa, Human African Trypanosomiasis, Production and 
Distribution of Malaria Sporozoite ELISAs; (7) maintains field-based 
research and program activities in numerous developing countries; and 
(8) provides marketing communications support for responsive, evidence-
based information targeted to the public, local and state health 
officials, international partners, and private organizations to inform 
health decisions, to prevent, and control parasitic diseases in the 
U.S. and abroad. Office of the Director (CWH1). (1) Works with CGH OD 
to ensure spending plans and budget are in line with the overall 
infectious disease strategies and priorities; (2) ensures that the CGH 
strategy is executed by the divisions and aligned with overall CDC 
goals; (3) co-develops execution strategies for the division with the 
branch chiefs; (4) provides program and science quality oversight; (5) 
builds leadership at the division and branch levels; (6) evaluates the 
strategies, focus, and prioritization of the division research, 
program, and budget activities; (7) identifies and coordinates 
synergies between the division and relevant partners; (8) ensures that 
policy development is consistent and appropriate; (9) facilitates 
research and program activities by providing leadership support; (10) 
proposes resource priorities throughout the budget cycle; (11) ensures 
scientific quality, ethics, and regulatory compliance; (12) fosters an 
integrated approach to research, program, and policy activities; and 
(13) liaises with HHS and partners as defined in the partnership 
management plan.
    Malaria Branch (CWHB). (1) Conducts malaria surveillance, 
prevention, and control in U.S. residents and visitors by monitoring 
the frequency and distribution of malaria cases that occur in U.S. 
residents and visitors and the efficacy and safety of antimalarial 
drugs for chemoprophylaxis and chemotherapy; (2) provides clinical 
advice and epidemiologic assistance on the treatment, control, and 
prevention of malaria in the U.S. and in malaria endemic countries; (3) 
provides information to the U.S. public and to appropriate agencies and 
groups on appropriate measures to prevent and control malaria; (4) 
provides consultation, technical assistance, and training to malaria-
endemic countries and to international and U.S. agencies and 
organizations on issues of malaria prevention and control; (5) conducts 
epidemiologic, laboratory, and field-based research projects, including 
laboratory and field studies on parasitic diseases to define biology, 
ecology, transmission dynamics, parasite species differences, host-
parasite relationships, diagnostics, host immune responses, populations 
at risk, and determinants of morbidity and mortality; (6) conducts 
laboratory studies of malaria parasites utilizing animal models and in 
vitro systems for parasitic relationships, chemotherapy, and vaccine 
evaluation studies; (7) conducts field studies of malaria prevention 
and control tools and strategies; and (8) conducts assessments of 
malaria monitoring and evaluation methods and program use of these 
methods.
    Parasitic Diseases Branch (CWHC). (1) Investigates outbreaks and 
unusual occurrences of parasitic diseases in concert with states, 
ministries of health, WHO, and other agencies and organizations; (2) 
conducts surveillance of foodborne disease outbreaks and other 
parasitic diseases in the U.S.; (3) provides reference and laboratory 
diagnostic services to physicians and laboratories; (4) transfers 
technologies and expertise in laboratory diagnosis of parasitic 
infections to public health laboratories; (5) provides consultation on 
the prevention, treatment, and management of parasitic diseases to 
clinicians, laboratorians, departments of health, and other agencies; 
and provides otherwise unavailable anti-parasitic drugs to healthcare 
providers and ensures compliance with FDA's regulations; (6) supports 
the agency's overall emergency response mandate; (7) conducts field and 
laboratory investigations and research on the etiology, biology, 
epidemiology, ecology, pathogenesis, immunology, genetics, host-
parasite relationships, chemotherapy and other aspects of parasitic 
diseases to develop new tools for identifying and controlling parasitic 
diseases; (8) develops and tests new laboratory methods and tools for 
improved diagnosis, control, and prevention of parasitic diseases, and 
conducts laboratory training courses for public health laboratories; 
(9) carries out and evaluates operational research to evaluate current 
strategies and develops new strategies to support programmatic 
activities for the control and elimination of parasitic diseases, and 
provides technical assistance to ministries of health, WHO, and other 
agencies and organizations for these programs; (10) provides training 
to Epidemic Intelligence Service officers, Emerging Infectious Disease 
fellows, American Society of Microbiology/Postdoctoral Fellows, 
Preventive Medicine Residents, public health prevention specialists, 
and other fellows and students; and (11) prepares and disseminates 
health communication materials on the prevention and treatment of 
parasitic diseases.
    Entomology Branch (CWHD). (1) Conducts surveillance, field 
investigations, and laboratory studies on the vectors of parasitic 
diseases of humans, with a focus on malaria, Chagas' disease, lymphatic 
filariasis, onchocerciasis, and leishmaniasis, with a particular 
emphasis on the anopheline vectors of malaria; (2) serves as WHO 
Collaborating Centers for pesticides resistance, anopheline vector 
identification, antimalarial drug evaluation, and vector control; (3) 
develops methods supporting the use of pesticides for control of 
vector-borne diseases, the management of insecticide resistance, and 
the monitoring of anti-

[[Page 22828]]

parasitic drugs; (4) serves as an international reference reagent and 
anopheline vector repository, providing materials, training, and 
information related to malaria vectors; and (5) provides entomological 
consultation, epidemic aid, and training to local, state, federal and 
foreign agencies and international health organizations on surveillance 
and control of vectors and vector-borne diseases.
    Division of Global Disease Detection and Emergency Response (CWJ). 
The Division of Disease Detection and Emergency Response (DGDDBER) 
supports CDC global efforts to strengthen public health systems abroad 
and build essential infrastructure in host countries. By providing 
leadership and coordinating with global partners, the Division 
increases preparedness and response to prevent and control naturally 
occurring and man-made threats to health. To carry out its mission, the 
Division performs the following functions: (1) Supports the 
requirements of the revised International Health Regulations by 
fostering collaborations, partnerships, integration, and resource 
leveraging to increase CDCs impact and achieve public health goals; (2) 
works with partners to build strong, transparent, and sustained global 
public health systems through training, consultation, capacity 
building, and technical assistance in applied epidemiology, public 
health surveillance, evaluation, and laboratory systems; (3) 
coordinates management and oversight of critical global health 
preparedness and emergency response activities across CDC, including 
situational awareness and partnership management at the global and 
regional level; (4) coordinates with and responds to requests from a 
wide array of internal CDC and external partners and stakeholders; and 
(5) provides stewardship and leadership support to global health 
preparedness programs housed in the Division.
    Office of the Director (CWJ1). (1) Provides leadership, oversight, 
evaluation and overall direction and management for the activities of 
the Division; (2) develops Division overall strategy, policies on 
planning, evaluation, management, and operations; (3) plans, allocates, 
and monitors resources; (4) provides liaison with other CDC 
organizations, other Federal agencies, national ministries of health, 
international organizations, non governmental organizations, private 
sector, and others that CDC cooperates with in global health programs 
and activities; and (5) promotes high standards in science and ethics 
among CDC's international activities.
    Global Disease Detection Branch (CWJB). The Global Disease 
Detection (GDDB) Branch: (1) Provides leadership and works with 
partners around the globe to increase preparedness for and mitigate the 
consequences of a catastrophic public-health event, whether by an 
intentional act of terrorism, or the natural emergence of a deadly 
infectious disease; (2) provides program support, resources and 
technical assistance to the seven Global Disease Detection (GDD) 
Centers around the world; (3) supports emerging infectious disease 
detection and response, pandemic influenza preparedness, health 
communications, zoonotic disease investigation, laboratory systems and 
biosafety, and training in field epidemiology and laboratory methods 
through the GDD Centers and other CDC field locations; (4) provides 
epidemic intelligence and response capacity to provide an early warning 
about international disease threats, and coordinates with partners 
throughout the U.S. government to provide rapid response; (5) leads and 
administers CDCs GDD program through coordination with relevant 
implementing programs across the Agency; (6) provides leadership, 
guidance, technical assistance support and resources for global 
infectious disease surveillance, applied epidemiologic and laboratory 
research, and response to emerging infectious disease threats; (7) 
provides resources and assists in developing country-level 
epidemiologic, laboratory, and other capacity to ensure country 
emergency preparedness and response to outbreaks and incidents of local 
importance and of international interests; and (8) maintains staff in 
the CDC Emergency Operations Center to manage, direct, coordinate and 
evaluate biosurveillance data from domestic and international networks 
and serve as a central focus for global outbreak and incident response 
activities.
    Global Health Security Branch (CWJC). The Global Health Security 
Branch (GHSB): (1) Serves as the principal point of coordination at CDC 
for global health security activities at HHS/OS, the DoS, the 
Department of Defense (DoD), USAID, USDA, other U.S. government 
agencies, and international and multilateral organizations; (2) aligns 
the activities formerly conducted by CDC units supporting the 
Biosecurity Engagement Program (BEP), the Defense Threat Reduction 
Agency Program and the International Influenza Unit (IIU); (3) provides 
support and coordination regarding the development of policies and 
priorities on international influenza; (4) serves as liaison with HHS 
and technical agency (CDC, NIH, FDA) representative for international 
pandemic preparedness related to budget formulation, program 
development, strategic planning, and global health policy development; 
(5) provides leadership, coordination, management and oversight of 
technical agency reports, briefing documents, and talking points for 
the HHS Secretary and staff related to global health policy; (6) 
provides technical assistance through training, and capacity building 
in supporting efforts to reduce the threat from chemical, biological, 
and nuclear disasters that are either natural or man-made; (7) provides 
liaison with the DoS Biosecurity Engagement Program and DoD Defense 
Threat Reduction Agency to coordinate on global biological threats; and 
(8) coordinates international aspects of CDC's terrorism preparedness 
and emergency response activities in collaboration with OPHPR.
    International Emergency and Refugee Health Branch (CWJD). The 
International Emergency and Refugee Health Branch (IERHB) applies 
public health and epidemiologic principles to improve the health of 
refugees, internally displaced persons (IDPs) and populations affected 
by complex humanitarian and other international emergencies. 
Specifically, it: (1) Coordinates, supervises, and monitors, CDC's work 
in international emergency settings and in refugee or displaced 
populations in collaboration with other U.S. government agencies, 
United Nations agencies, and non-governmental organizations; (2) 
provides direct technical assistance to refugees/IDPs and emergency 
affected populations in the field, focusing on rapid health and 
nutrition assessments, public health surveillance, epidemic 
investigations, communicable disease prevention and control and program 
evaluation; (3) develops and implements operational research aimed at 
developing more effective public health and nutrition interventions in 
emergency-affected populations; (4) plans, implements, and evaluates 
training courses and workshops to help strengthen CDC technical 
capacity in emergency public health of CDC, as well as that of other 
U.S. government agencies, international and private voluntary 
organizations, and schools of public health; (5) develops technical 
guidelines on public health issues associated with international 
complex humanitarian emergencies; (6) serves as the CDC liaison with 
other international, bilateral, and non-governmental relief 
organizations

[[Page 22829]]

involved with humanitarian emergencies; and (7) helps prepare CDC 
country offices, host countries, and local partners to respond to the 
full range of public health emergencies.
    Delete in its entirety the title and functional statements for the 
Division of Global AIDS (CVJG) within the National Center for HIV/AIDS, 
Viral Hepatitis, STD and TB Prevention.
    Delete in its entirety the title and functional statement for the 
International Emergency and Refugee Health Branch (CTBBD) within the 
Division of Emergency and Environmental Health Services of the National 
Center for Environmental Health.

     Dated: April 19, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-9910 Filed 4-29-10; 8:45 am]
BILLING CODE 4163-18-M